{"id":25061,"date":"2022-10-21T10:15:34","date_gmt":"2022-10-21T14:15:34","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=25061"},"modified":"2022-10-21T10:19:37","modified_gmt":"2022-10-21T14:19:37","slug":"pipeline-update-mobileye-sets-terms-new-filings-remain-slow","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/pipeline-update-mobileye-sets-terms-new-filings-remain-slow\/","title":{"rendered":"Pipeline Update: Mobileye Sets Terms; New Filings remain slow"},"content":{"rendered":"<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Company: Acrivon Therapeutics, Inc.<br \/>\nSymbol: ACRV (Nasdaq)<br \/>\nDescription: They are a clinical stage biopharmaceutical company developing precision oncology medicines that we match to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing our proprietary proteomics-based patient responder identification platform.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nMarket Cap: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Morgan Stanley, Jefferies, Cowen, Piper Sandler<br \/>\nLink to Prospectus:<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1781174\/000095012322010286\/d383050ds1.htm\"> Filed: 10-17-22<\/a><\/p>\n<p><strong><span style=\"text-decoration: underline;\">TERMS ADDED<\/span><\/strong><\/p>\n<p>Company: Mobileye Global Inc.<br \/>\nSymbol: MBLY (Nasdaq)<br \/>\nDescription: Mobileye is a leader in the development and deployment of advanced driver assistance systems (\u201cADAS\u201d) and autonomous driving technologies and solutions.<br \/>\nShares: 41 million<br \/>\nPrice Range: $18.00-$20.00<br \/>\nMarket Cap: $14.3b-$15.9b<br \/>\nTrade Date: Wednesday, 10\/26<br \/>\nUnderwriters: Goldman Sachs, Morgan Stanley, Evercore ISI, Barclays, Citigroup, BofA Securities, RBC Capital Markets, Mizuho, Wolfe | Nomura Alliance, BNP PARIBAS<br \/>\nCo-Manager(s): Cowen, Siebert Williams Shank, PJT Partners, MUFG, Needham &amp; Company, Raymond James, Loop Capital Markets, Blaylock Van, Academy Securities, Drexel Hamilton, Independence Point Securities, CICC, Cabrera Capital<br \/>\nMarkets, Guzman &amp; Company<\/p>\n<p><span style=\"font-weight: 400;\">Link to Prospectus:<\/span><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1910139\/000110465922109469\/tm227410-19_s1a.htm\"><span style=\"font-weight: 400;\">Terms Added: 10-18-22<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW FILINGS &nbsp; Company: Acrivon Therapeutics, Inc. Symbol: ACRV (Nasdaq) Description: They are a clinical stage biopharmaceutical company developing precision oncology medicines that we match to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing our proprietary proteomics-based patient responder identification platform. Shares: TBD Price Range: TBD Market Cap: TBD[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-25061","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=25061"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25061\/revisions"}],"predecessor-version":[{"id":25064,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25061\/revisions\/25064"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=25061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=25061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=25061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}